Ann: PharmAust Canine Trial Update clarification, page-49

And Lastly you were trying to con potential shareholders that the sp would be well above $1 so we were both wrong.
But to me it's you and other positive posters that have scared away new investors with all the predictions around higher sp, that 2018, 2019, 2020, 2021 and 2022 would be the year of PAA.
So where are back to where we were in 2016, human cancer trials treatment which we were lead to believe no adverse affects which was a falsehood.
Move forward six years we have a new tablet, new formulation but not being used to trial on mnd instead of human cancer.
We still have on going, never ending phrase 2 canine trials and still the same old announcements around moving to a phrase 2 human cancer trial.
Over the 6 years between 2016 to 2022 we have been told that mpl would be trialled on a number of different cancers, covid and other diseases but nothing ever gets done.